2seventy bio, Inc. (TSVT)
(Real Time Quote from BATS)
$4.23 USD
-0.06 (-1.40%)
Updated Apr 26, 2024 01:08 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/1/24 |
---|---|
Current Quarter | -0.72 |
EPS Last Quarter | -1.11 |
Last EPS Surprise | 9.02% |
ABR | 2.43 |
Earnings ESP
|
31.94% |
---|---|
Current Year | -1.39 |
Next Year | 0.07 |
EPS (TTM) | -4.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.93M | 20.79M | 100.56M | 116.82M |
# of Estimates | 3 | 2 | 4 | 4 |
High Estimate | 12.82M | 26.66M | 154.23M | 213.22M |
Low Estimate | 10.47M | 14.92M | 61.30M | 59.25M |
Year ago Sales | 41.62M | 36.05M | 100.39M | 100.56M |
Year over Year Growth Est. | -71.34% | -42.33% | 0.17% | 16.17% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.72 | -0.46 | -1.39 | 0.07 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.49 | -0.21 | -0.09 | 1.39 |
High Estimate | -0.49 | -0.21 | -0.09 | 1.39 |
Low Estimate | -0.95 | -0.71 | -2.33 | -1.31 |
Year ago EPS | -1.08 | -0.83 | -4.42 | -1.39 |
Year over Year Growth Est. | 33.33% | 44.58% | 68.55% | 105.27% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 2 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.72 | -0.46 | -1.39 | 0.07 |
7 Days Ago | -0.72 | -0.46 | -1.39 | 0.07 |
30 Days Ago | -0.61 | -0.44 | -1.36 | 0.11 |
60 Days Ago | -0.55 | -0.44 | -1.34 | -0.03 |
90 Days Ago | -0.34 | -0.43 | -1.54 | -1.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.49 | -0.21 | -0.09 | 1.39 |
Zacks Consensus Estimate | -0.72 | -0.46 | -1.39 | 0.07 |
Earnings ESP | 31.94% | 54.35% | 93.54% | 1,885.71% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.11 | -1.00 | -0.83 | -1.08 | NA |
Estimate | -1.22 | -1.31 | -1.04 | -1.19 | NA |
Difference | 0.11 | 0.31 | 0.21 | 0.11 | 0.19 |
Surprise | 9.02% | 23.66% | 20.19% | 9.24% | 15.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more